Concourse Financial Group Securities, Inc. Bausch Health Companies Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 500 shares of BHC stock, worth $3,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 0
Infinity%
Holding current value
$3,900
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding BHC
# of Institutions
255Shares Held
253MCall Options Held
5.53MPut Options Held
16.5M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$271 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$229 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$206 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$122 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$101 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.82B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...